CoChat

Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity Disorder

BARRICKMAN, LES L., PERRY, PAUL J., ALLEN, A.J., KUPERMAN, SAMUEL, ARNDT, STEPHAN V., HERRMANN, KENNETH J., SCHUMACHER, ELIZABETH · 1995 · Journal of the American Academy of Child & Adolescent Psychiatry

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Abstract

Objective In the treatment of attention-deficit hyperactivity disorder (ADHD), the efficacy of the tricyclic antidepressants and monoamine oxidase inhibitor antidepressants has been compared with that of both placebo and the stimulants (methylphenidate and/or dextroamphetamine). However, the effectiveness of bupropion has been contrasted only with placebo. The primary aim of this study was to contrast the efficacy of bupropion with that of methylphenidate in the treatment of ADHD.Method A double-blind, crossover design was used in this study. After a 14-day medication washout period, 15 ADHD subjects (7 to 17 years old) were randomized to either methylphenidate or bupropion for 6 weeks, washed out for an additional 2 weeks, and then "crossed over" to the other drug. Methylphenidate was titrated to the maximum effective dose of 0.4 to 1.3 mg/kg per day (mean 0.7 mg/kg per day) and bupropion was titrated to an effective dose ranging from 1.4 to 5.7 mg/kg per day (mean 3.3 mg/kg per day).Results Both methylphenidate and bupropion produced significantly greater (p < .001) and equivalent improvement on the Iowa-Conners Teacher's Rating Scale according to both the subjects' parents and teachers. The same pattern of improvement was also noted for improvement on the Clinical Global Impression Scale, Kagan's Matching Familiar Figures Test, Continuous Performance Test, Children's Depression Inventory, Children's Manifest Anxiety Scale, and Rey Auditory-Verbal Learning Test.Conclusions In this double-blind, crossover trial, bupropion and methylphenidate were both effective and did not differ in their overall efficacy as treatments for ADHD.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004583-199505000-00017

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Sudden death in children treated with a tricyclic antidepressant, 1990, Med Lett, 32, 53

Cited by

See all 254

Metadata

Authors
BARRICKMAN, L. L., PERRY, P. J., ALLEN, A. J., KUPERMAN, S., ARNDT, S. V., HERRMANN, K. J., & SCHUMACHER, E.
Affiliations
University of Iowa (US)
Corresponding author
PERRY, PAUL J.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
1995-05
Volume
34
Issue
5
Pages
649-657
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2049710132
Cited by
254
References
39
Citations by year
2025: 2 · 2024: 5 · 2023: 5 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 3 · 2012: 7
FWCI
9.60
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
Keywords
attention deficit hyperactivity disorder, bupropion, methylphenidate, tricyclic antidepressants, monoamine oxidase inhibitors, treatment efficacy, children and adolescents
MeSH terms
Adolescent, Attention Deficit Disorder with Hyperactivity, Child, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Methylphenidate, Placebos, Bupropion, Treatment Outcome, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity Disorder. https://app.cochat.ai/papers/10.1097/00004583-199505000-00017
The paper
BARRICKMAN, L. L., PERRY, P. J., ALLEN, A. J., KUPERMAN, S., ARNDT, S. V., HERRMANN, K. J., & SCHUMACHER, E. (1995). Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/00004583-199505000-00017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.